Skip to main content

Drug Interactions between Amondys 45 and Voxzogo

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between Amondys 45 and Voxzogo. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Amondys 45

A total of 4 drugs are known to interact with Amondys 45.

Voxzogo

A total of 122 drugs are known to interact with Voxzogo.

Drug and food/lifestyle interactions

Moderate

vosoritide food/lifestyle

Applies to: Voxzogo (vosoritide)

Vosoritide may cause transient decreases in blood pressure. To reduce the risk of low blood pressure and its associated symptoms, you should have adequate food intake before vosoritide administration and should drink approximately 8 to 10 ounces of liquids within the hour prior to vosoritide injection. Tell your doctor if you experience fatigue, nausea, dizziness, or lightheadedness after vosoritide injection. Avoid driving or operating hazardous machinery until you know how this medication affects you and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer